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Invited Commentary
The Need for Research on Treatments of Chronic Depression
Pim Cuijpers, PhD; Marcus J. H. Huibers, PhD; Toshi A. Furukawa, PhD, MD
Chronic depression is one of the most challenging types of the
major depressive disorders to treat, as many patients with
chronic depression are resistant to several treatments, leav-
ing clinicians with no or few treatment options available. From
a public health perspective,
chronic depressive disorders
are also problematic because
they are responsible for a con-
siderable part of the disease burden of depression. The devel-
opment of effective treatments for chronic depression is there-
fore one of the most important challenges for clinical research
in depression.
From this perspective, it is remarkable that only a small
number of randomized trials have examined the effects of treat-
ments of chronic depression. Although more than 500 ran-
domized trials have examined the effects of psychotherapies
for depression in adults, in a meta-analysis of trials of psycho-
therapies for chronic depression, only 16 trials were in-
cluded, 7 of which were in patients with dysthymia.1 Among
the hundreds of randomized trials on selective serotonin reup-
take inhibitors and tricyclic antidepressants for depression, a
recent meta-analysis found only 20 trials on chronic depres-
sion, 19 of which were in patients with dysthymia.2 A meta-
analysis on combined treatments for depression, which is
recommended in most treatment guidelines, included only
8 trials.3 Considering the clinical and public health impor-
tance of chronic depression, research on this topic is needed.
The study by Schramm and colleagues4 in this issue of
JAMA Psychiatry comparing the Cognitive Behavioral Analy-
sis System of Psychotherapy (CBASP) with supportive therapy
(SP) is therefore a welcome addition to the existing research
on therapy for chronic depression. Several important re-
search questions are addressed in this trial. One is whether a
therapy that has been specifically developed for the treat-
ment of chronic depression (CBASP) should be preferred in-
stead of a nonspecific yet credible psychotherapy (SP). The
CBASP is the only therapy that has been specifically devel-
oped for the treatment of chronic depression, and it seems safe
to assume that this treatment is beneficial to patients, as it is
found to result in good rates of response and remission, and
superior effects compared with bona fide, nondirective SP.4
An additional particular strength of the study by Schramm et
al4 is that it allowed enough length and density of treatment
for psychotherapy to demonstrate an effect in the acute phase
and show growing effects during almost 1 year of treatment.
Like other studies, however, the study by Schramm et al4
also leaves many important questions unanswered. Most treat-
ment guidelines recommend a combination of pharmaco-
therapy and psychotherapy for treatment of chronic depres-
sion, but it is not clear which psychotherapy should be given.
The CBASP would certainly be a good candidate. However, the
study by Schramm and colleagues4 was focused on mono-
therapy without concomitant pharmacotherapy in patients
who mostly preferred psychotherapy. How CBASP, either alone
or in combination, would fare in populations that preferred
pharmacotherapy or combination therapy or had no prefer-
ence is still not clear. Nor is the clinically more relevant ques-
tion of which psychotherapy or combination would be pref-
erable for which patients.
A considerable number of head-to-head comparisons be-
tween different types of psychotherapy have shown that the
effects of these different types are comparable with each other,
with no or only small and nonsignificant differences.5 Sup-
portive therapy is an exception, with several studies showing
that it is somewhat less effective than other therapies. How-
ever, this finding may be associated with the fact that SP is of-
ten used as a control condition, and may be owing to re-
searcher allegiance, the conviction held by a researcher that a
specific treatment is superior to other treatments.6 Although
CBASP is probably effective and somewhat more effective than
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SP, it is still not clear whether CBASP is more effective than
therapies that were not specifically designed for chronic de-
pression, such as cognitive behavioral therapy and interper-
sonal therapy. Both cognitive behavioral therapy and inter-
personal therapy have also been found to be effective in the
treatment of chronic depression,1 so whether CBASP is supe-
rior to these therapies has yet to be established.
Patients in both groups in the study by Schramm and
colleagues4 showed a considerable improvement in depres-
sive symptoms, and the numbers needed to treat for CBASP
compared with SP were 5 and 6, respectively, for response and
3 and 7, respectively, for remission. These are not large differ-
ences, but are still remarkable in this population of patients
with treatment-refractory chronic depression. Medicine, psy-
chiatric or nonpsychiatric, can only rarely work miracles and
the median efficacy of standard drug therapies, both in medi-
cine and psychiatry, hover around effect sizes of 0.3 and 0.4.7
The efficacy of around 0.3 in effect size of CBASP compared
with nonspecific bona fide psychotherapy would represent an
addition to the armamentarium in psychiatry as great as, or as
small as, many other advances in medicine.
Perhaps the most important result of this study is that it
confirms what has been found in earlier, smaller trials; namely,
that patients with chronic depression can improve. The re-
sponse rates are overall somewhat lower than in patients with
nonchronic depressive disorders after treatment with phar-
macotherapy or with psychotherapy, but not very much. That
is encouraging news for patients and clinicians.
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